Prophylactic or therapeutic agent for oral diseases

US9730883B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9730883-B2
Application numberUS-201214236849-A
CountryUS
Kind codeB2
Filing dateAug 3, 2012
Priority dateAug 5, 2011
Publication dateAug 15, 2017
Grant dateAug 15, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a novel lactic acid bacterium strain which is capable of suppressing production of volatile sulfur compounds by oral bacteria, has no cariogenicity and no causative role in infective endocarditis, and is safe in an oral cavity, and provided is an agent for preventing, improving and/or treating oral diseases and discomforts by use of the bacterial strain. An agent for preventing and/or treating an oral disease, containing, as an active ingredient, at least one lactic acid bacterium selected from Lactobacillus crispatus, Lactobacillus fermentum, Lactobacillus gasseri , and Streptococcus mitis and having all of the following properties (1) to (6): (1) having no ability to produce a volatile sulfur compound (VSC); (2) having no ability to produce water-insoluble glucan; (3) having adhesiveness to a tooth surface and/or an oral cell; (4) having a growth inhibitory effect on a bad breath-causing bacterium and/or a periodontal pathogen; (5) having no causative role in infective endocarditis; and (6) having no cariogenicity.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for inhibiting growth of at least one pathogenic bacterium, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503), wherein the at least one pathogenic bacterium is at least one selected from the group consisting of Porphyromonas gingivalis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Streptococcus sobrinus, Fusobacterium nucleatum , and Tannerella forsythia. 2. The method of claim 1 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 3. The method of claim 1 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 4. The method according to claim 3 , wherein the food or the drink is a fermented product. 5. The method according to claim 1 , wherein the at least one pathogenic bacterium is at least one selected from the group consisting of Porphyromonas gingivalis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, Streptococcus mutans , and Streptococcus sobrinus. 6. The method according to claim 1 , wherein the at least one pathogenic bacterium is at least one selected from the group consisting of Porphyromonas gingivalis, Fusobacterium nucleatum , and Tannerella forsythia. 7. A method for preventing and/or improving bad breath, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 8. The method of claim 7 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 9. The method according to claim 8 , wherein the food or the drink is a fermented product. 10. The method of claim 7 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 11. A method for preventing and/or treating gingivitis, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 12. The method of claim 11 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 13. The method according to claim 12 , wherein the food or the drink is a fermented product. 14. The method of claim 11 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 15. A method for improving bad breath, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 16. The method of claim 15 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 17. The method according to claim 16 , wherein the food or the drink is a fermented product. 18. The method of claim 15 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 19. A method for treating gingivitis, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 20. The method of claim 19 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 21. The method according to claim 20 , wherein the food or the drink is a fermented product. 22. The method of claim 19 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium.

Assignees

Inventors

Classifications

  • Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates · CPC title

  • Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title

  • Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title

  • Bacteria; Culture media therefor · CPC title

  • Adding ingredients (adding preservatives A23B70/10) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9730883B2 cover?
Provided is a novel lactic acid bacterium strain which is capable of suppressing production of volatile sulfur compounds by oral bacteria, has no cariogenicity and no causative role in infective endocarditis, and is safe in an oral cavity, and provided is an agent for preventing, improving and/or treating oral diseases and discomforts by use of the bacterial strain. An agent for preventin…
Who is the assignee on this patent?
Okumura Takekazu, Terai Tomohiko, Nakao Masumi, and 10 more
What technology area does this patent fall under?
Primary CPC classification A61K8/99. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).